Chantal Heijnen for STAT

STAT+ | Miriam Merad’s 20-year quest to understand one cell is starting to rewrite the rules of cancer immunotherapy

After decades studying macrophages, Miriam Merad believes these overlooked immune cells could unlock a new frontier in cancer treatment.

By Angus Chen

STAT+ | Eli Lilly, NVIDIA team up to build pharma’s biggest AI supercomputer

Eli Lilly to use NVIDIA chips in new supercomputer billed as the most powerful in the pharmaceutical industry. Will run 100% on renewable energy.

By Brittany Trang

STAT+ | UnitedHealth wants to employ more of its doctors

UnitedHealth Group, with 90,000 doctors under its umbrella, wants to exert greater control by directly employing doctors instead of affiliating with them.

By Tara Bannow

Adobe

STAT+ | Psychedelic-like therapy posts encouraging early data, as regulators clear at-home testing

Delix Therapeutics' drug called zalsupindole is a neuroplastogen designed to provide the therapeutic benefits of classic psychedelics without the 'trip.'

By Elaine Chen

Texas lawsuit against companies behind Tylenol asserts unproven claims of autism risk

Texas Attorney General Ken Paxton accused Johnson & Johnson and Kenvue of deceptively marketing Tylenol to pregnant mothers.

By Associated Press

Opinion: Global security is impossible without sufficient support for global health

Cutting U.S. support for global health needs in favor of more military spending is a false choice, writes Seth Berkley.

By Seth Berkley

Andrew Harnik/Getty Images

Opinion: America needs a trusted national patient registry for leucovorin and autism

Fast-tracking leucovorin for autism may help families sooner, but a national evidence registry is needed to track how the drug performs in real life.

By Srinivas Sridhar